Anthem Denied Your Proton Therapy? How to Appeal

Proton beam therapy is an advanced form of radiation therapy that uses protons instead of traditional X-ray photons to target tumors with greater precision, reducing radiation exposure to surrounding healthy tissue. Despite strong clinical evidence and NCCN guideline endorsement for specific cancer types, Anthem aggressively denies proton therapy claims — making it one of the most frequently denied cancer treatments in the country.

Why Insurers Deny Proton Therapy Claims

Experimental/investigational classification: Anthem's most common denial basis is classifying proton therapy as experimental or investigational for the patient's specific cancer type. While proton therapy has FDA clearance and strong evidence for numerous indications, Anthem's Clinical Policy Bulletin (CPB) restricts coverage to a narrow list of approved indications. For cancer types not on Anthem's CPB list, Anthem denies as unproven — even when the treating radiation oncologist has determined it is the most appropriate treatment based on tumor location and tissue-sparing requirements.

Cost-driven "equivalent alternative" denials: Proton therapy is more expensive per course than conventional radiation (IMRT). Anthem frequently argues that conventional IMRT is "equivalent" to proton therapy for the patient's cancer type, even when the treating oncologist has documented specific dosimetric advantages for the individual patient's anatomy. This argument is particularly weak when a patient-specific dosimetric comparison demonstrates the differential.

Medical necessity disputes: Even for cancer types where Anthem acknowledges proton therapy may be appropriate, Anthem imposes specific criteria — tumor location, patient age, prior radiation history, proximity to critical structures — and denies when documentation doesn't clearly satisfy every criterion.

Reviewer qualifications issue: A proton therapy denial must be reviewed by a board-certified radiation oncologist. If a non-specialist denied your claim, this is a procedural grounds for appeal. ICD-10 codes frequently implicated include C71.9 (malignant neoplasm of brain), C11.9 (nasopharyngeal carcinoma), C41.2 (malignant neoplasm of vertebral column — chordoma), and pediatric solid tumor codes C69–C76.

How to Appeal

Step 1: Request the Complete Claims File and Verify the Reviewer's Qualifications

Contact Anthem and request the full file including the specific CPB applied, the reviewer's credentials and specialty (must be a board-certified radiation oncologist), and the specific criteria your claim failed to meet. If the denial was made by a non-specialist, this is a strong procedural argument. Anthem's CPBs are accessible at anthem.com/provider/policies.

Step 2: Get a Comprehensive Letter and Dosimetric Comparison From Your Radiation Oncologist

This is the most critical document in the appeal. It should include: complete cancer diagnosis with staging, pathology, and molecular characterization; tumor location and proximity to critical structures (brainstem, spinal cord, optic nerves, heart, salivary glands, kidneys); a side-by-side comparative dosimetric analysis showing radiation dose to the tumor and surrounding critical structures under both a proton plan and a conventional IMRT plan; clinical rationale for proton therapy superiority including expected reduction in acute and late toxicity; NCCN guideline citations and ASTRO model policy references specific to your cancer type; and for pediatric cases, long-term reduction in secondary cancer risk and developmental toxicity.

Step 3: File the Internal Appeal With an Expedited Processing Request

Cancer treatment delays affect outcomes. Always request expedited appeal processing — under the ACA (42 U.S.C. § 300gg-19), insurers must respond to urgent appeals within 72 hours, and cancer treatment qualifies. Address Anthem's denial directly: if denied as experimental, demonstrate NCCN endorsement; if denied as not medically necessary, present the dosimetric comparison. The NCCN guidelines recommend proton therapy for pediatric cancers broadly, CNS tumors, head and neck cancers near critical structures, chordomas, chondrosarcomas, hepatocellular carcinoma when other therapies are not feasible, and re-irradiation cases. If NCCN recommends proton therapy for your cancer type, Anthem's "experimental" classification is indefensible.

Step 4: Request a Peer-to-Peer Review With a Radiation Oncologist

Your radiation oncologist should speak directly with Anthem's medical director. The dosimetric argument requires physician-to-physician discussion of radiation physics — an argument that is impossible to make effectively in written form alone without the physicist's dose-volume histogram data to support it.

Step 5: Pursue External Independent Review: Complete Guide" class="auto-link">External Review Immediately If Denied

For cancer treatment, you may qualify for expedited external review that bypasses the full internal appeal process for life-threatening conditions under 45 CFR 147.136. Independent radiation oncologists at IROs reverse proton therapy denials at significant rates when the dosimetric comparison is included. File regulatory complaints with your state Department of Insurance, citing any state cancer treatment access laws requiring NCCN-guideline coverage.

Step 6: Cite the ASTRO Model Policy and State Cancer Treatment Laws

The American Society for Radiation Oncology (ASTRO) publishes model coverage policies identifying clinical situations where proton therapy offers a clear dosimetric advantage. When your case falls within ASTRO's recommended indications, this carries significant weight with external reviewers. Several states have enacted laws requiring coverage of cancer treatments recommended by NCCN guidelines or prohibiting denial solely on cost grounds when clinical evidence supports the treatment.

What to Include in Your Appeal

• Radiation oncologist's letter of medical necessity with full cancer diagnosis, staging, and pathology — this is the anchor document for the entire appeal
• Comparative dosimetric analysis: side-by-side proton plan vs. IMRT plan showing dose to tumor and critical structures in dose-volume histogram format — this is the single most powerful piece of evidence
• NCCN guideline section recommending proton therapy for your specific cancer type, with the relevant pages highlighted
• ASTRO model policy reference for your clinical indication
• Denial letter with specific criteria cited and reviewer's credentials — if the reviewer is not a radiation oncologist, assert this procedural deficiency prominently

Fight Back With ClaimBack

An Anthem proton therapy denial is a serious obstacle, but it is frequently reversible. The dosimetric comparison is the single most powerful piece of evidence — it turns an abstract clinical argument into specific, patient-level data showing exactly why conventional radiation is inferior for your case. A treatment endorsed by NCCN guidelines cannot credibly be classified as experimental. ClaimBack generates a professional appeal letter in 3 minutes incorporating NCCN guideline citations, ASTRO model policy references, and the specific CPB arguments that give you the best chance of approval. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal